Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73364
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73364
Character Range: 317779–319072

73364              Analysis of tumour tissue, requested by a specialist or consultant physician, that:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  400.00
                   (a) is for:
                   (i) the characterisation of MYC gene rearrangement; and
                   (ii) if the results of the characterisation mentioned in subparagraph (i) are positive—the characterisation of either or both of BCL2 gene rearrangement and BCL6 gene rearrangement; and
                   (b) is for a patient:
                   (i) for whom MYC immunohistochemistry is non‑negative; and
                   (ii) with clinical or laboratory evidence, including morphological features, of diffuse large B‑cell lymphoma or high grade B‑cell lymphoma; and
                   (c) is not performed in conjunction with item 73365
                   Applicable only once per lifetime